X
Xiaojing Du
Researcher at Fudan University
Publications - 3
Citations - 73
Xiaojing Du is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Icotinib. The author has an hindex of 1, co-authored 3 publications receiving 2 citations. Previous affiliations of Xiaojing Du include First Affiliated Hospital of Wenzhou Medical University.
Papers
More filters
Journal ArticleDOI
Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.
TL;DR: The molecular mechanisms underlying resistance to third-generation EGFR inhibitors and the ongoing efforts to address and overcome this chemoresistance are summarized.
Journal ArticleDOI
Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization.
TL;DR: In this article, the potential predictive and prognostic roles of LAG-3 and PD-L1 as serum biomarkers in hepatocellular carcinoma patients underwent TACE treatment were explored.
Journal ArticleDOI
Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma.
Feng Qi,Xiaojing Du,Xiaojing Du,Zhiying Zhao,Ding Zhang,Mengli Huang,Yuezong Bai,Biwei Yang,Wenxing Qin,Jinglin Xia,Jinglin Xia +10 more
TL;DR: Wang et al. as mentioned in this paper employed Cox analysis and machine learning algorithms to establish a lncRNA-based prognostic model for hepatocellular carcinoma (HCC), and developed a nomogram model to predict overall survival and odds of death for HCC patients.